Rasilez 300mg Tablet FC
By Rasilez
Rx
7 Tablet FC in a Strip

Composition
Aliskiren(300mg)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
September, 2025

liver
Rasilez 300mg Tablet FC needs to be used cautiously in individuals with severe liver disease. It may be necessary to adjust the dosage of Rasilez 300mg Tablet FC in such cases. It is important to seek advice from your healthcare provider before taking this medication. There is limited data on the use of Rasilez 300mg Tablet FC in individuals with severe liver conditions. However, no dosage adjustments are typically required for patients with mild to moderate liver disease.

kidney
Rasilez 300mg Tablet FC requires caution in patients with kidney disease. Dose adjustment may be necessary, so consult your doctor. Limited data is available on its use in such patients. Regular monitoring of creatinine and potassium levels while on this medication is advised.

alcohol
When taking Rasilez 300mg Tablet FC, be cautious as it can lead to increased drowsiness when combined with alcohol.

driving
Rasilez 300mg Tablet FC may reduce alertness, affect vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Rasilez 300mg Tablet FC is not safe to use during pregnancy due to the risk it poses to the developing baby. In rare life-threatening cases, a doctor may prescribe it if the benefits outweigh the risks. Please consult your doctor before use.

breastfeeding
Rasilez 300mg Tablet FC is likely safe while breastfeeding. Limited data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | Delta Amino Acids Derivatives |
Therapeutic Class | - |
Action Class | Renin inhibitors |
₹408.5
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025